Kenneth Bate is Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL). They have made 9 open-market trades across 2 companies since 2013, most recently 2025-11-05.
CIK 0001210238
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MDGL | 8,896 | $3.6M |
| BMRN | 11,875 | $679K |
| EPZM | 17,054 | $25K |
| VNDA | 5,000 | $19K |
| AVEO | 375 | $6K |
| CBST | 9,615 | — |
| Total | $4.3M |
Shares reported on the most recent Form 4, priced at the 2025-11-07 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDGL | SELL | 2025-11-05 | 2025-11-07 | $484.30 | $16.0M | +11.6% | +14.2% | -6.9% |
| MDGL | SELL | 2025-08-15 | 2025-08-15 | $365.17 | $7.1M | +19.9% | +20.0% | +45.2% |
| MDGL | SELL | 2025-02-27 | 2025-02-28 | $356.51 | $14.0M | -2.3% | -1.1% | -19.4% |
| MDGL | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $252.68 | $16.0M | -5.3% | -6.0% | +11.2% |
| CBST | SELL | 2014-02-03 | 2014-02-04 | $72.15 | $451K | N/A | N/A | N/A |
| CBST | SELL | 2014-01-09 | 2014-01-09 | $70.00 | $700K | N/A | N/A | N/A |
| CBST | SELL | 2013-12-02 | 2013-12-03 | $67.63 | $845K | N/A | N/A | N/A |
| CBST | SELL | 2013-06-03 | 2013-06-03 | $54.95 | $137K | N/A | N/A | N/A |
| CBST | SELL | 2013-05-15 | 2013-05-17 | $48.41 | $121K | N/A | N/A | N/A |
| CBST | SELL | 2013-03-06 | 2013-03-07 | $47.50 | $238K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.